1Laven JS,Imani B,Eijkemans MJ,et al.New approaches to PCOS and other forms of anovulation[J].Obstet Gynecol Surv,2002,57 (11):755-767.
2The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS)[J].Human Reprod,2004,19(1):41-47.
3Coviello AD,Legro RS,Dunaif A.Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance[J].Clin Endocrinol Metab,2006,91(2):492-497.
4Villavicencio A,Bacallao K,Avellaira C,et al.Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia[J].Gynecol Oncol,2006,2[Epub ahead of print].
5Quezada S,Avellaira C,Johnson MC,et al.Evaluation of steroid receptors,coregulators,and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome[J].Fertil Steril,2006,85 (4):1017-1026.
6Gregory CW,Wilson EM,Apparao KB,et al.Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium[J].Clin Endocrinol Metab,2002,87(6):2960-2966.
7Apparao KB,Lovely LP,Yaoting G,et al.Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome[J].Biol Reprod,2002,66(2):297-304.
8Lovely LP,Appa RKB,Gui Y.Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa)[J].Steroid Biochem Mol Biol,2000,74 (4):235-241.
9Deugarte CM,Bartolucci AA,Azziz R.Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment[J].Fertil Steril,2005,83 (5):1454-1460.
10Ducluzeau PH,Cousin P,Malvoisin E,et al.Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome[J].Clin Endocrinol Metab,2003,88 (8):3626-363 l.
二级参考文献24
1[1]Holness MJ, Munns MJ, Sugden MC. Current concepts concerning the role of leptin in reproductive function. Molecular and Cellular Endocrinology, 1999, 157: 11-20
2[2]EI Orabi H, GhaliaAA, KhalifaA, etal. Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome. Clin Biochem,1999, 32:71-75
3[3]Pirwany IR, Fleming R, Sattar N, et al. Circulating leptin concentrations and ovarian function in polycystic ovary syndrome. Eur J Endocrinol,2001, 145:289-294
4[4]Telli MH, Yildirim M, Noyan V, et al. Serum leptin levels in patients with polycystic ovary syndrome. Fertil Steril, 2002, 77:932 - 935.
5[5]Remsberg K, Talbott E, Zborowski J, et al. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome. Fertil Steril, 2002 , 78:479-482
6[6]Jacobs HS, Conway GS. Leptin, polycystic ovaries and polycystic ovary syndrome. Human Reproduction Update, 1999, 5: 166- 171
7[7]Laughlin GA, Morales AJ, Yen SS. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia. J Clin Endocrinol Metab, 1997, 82: 1692- 1696
8[8]Rouru J, Anttila L, Koskinen P, et al. Serum leptin concentrations in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1997,82:1697 - 1700
9[9]Muller B , Ertl J, Gerl M, etal. Leptin impairs metabolic actions of insulinin isolated rat adipocytes, J Biol Chem, 1997, 272:10585 -10593
10Elliott JL,Hosford SL,Demopoulos RI,et al.Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors,management,and prognosis.South Med J,2001,94(5): 529-31.
9Branigan EF, Estes MA. Treatment of chronic anovulatio-on resistant to clomiphenecitrate (cc) by using oral contraceptive ovarian suppression followed by repeat(CC), treatment [J] . Fertil,2005,71 (3) : 544- 546.
10Ghina G,William HK,Michael BA,et al.Effect of rosiglitazoneon spontaneous and clomiphene citrate-induced ovulation in womenpolycystid ovary syndrome[J].Fertil Steril,2003,79(3):562-566.
